HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hermann Künzer Selected Research

ZK253

2/2004Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hermann Künzer Research Topics

Disease

1Breast Neoplasms (Breast Cancer)
02/2004
1Neoplasms (Cancer)
02/2004

Drug/Important Bio-Agent (IBA)

1ZK703IBA
02/2004
1ZK253IBA
02/2004
1Fulvestrant (Faslodex)FDA Link
02/2004
1Estrogens (Estrogen)FDA Link
02/2004
1Hormones (Hormone)IBA
02/2004
1Estrogen ReceptorsIBA
02/2004
1TamoxifenFDA LinkGeneric
02/2004
1Urea (Carbamide)FDA LinkGeneric
02/2004
1Selective Estrogen Receptor Modulators (SERM)IBA
02/2004
1Estrogen Receptor Modulators (Antiestrogen)IBA
02/2004

Therapy/Procedure

1Aftercare (After-Treatment)
02/2004